心上脂肪组织的增加与扩大心肌病的左心室逆转重塑有关
Yuanwei Xu1, Jiajun Guo1, Yangjie Li1
1Department of Cardiology, Sichuan University, Chengdu, Sichuan Province, 610041, People's Republic of China.
Cardiovascular diabetology
|December 19, 2024
概括
在治疗后扩张性心肌病患者中,心上脂肪组织 (EAT) 增加,与心脏功能改善相关. 这表明EAT在心力衰竭恢复中的潜在保护作用.
科学领域:
- 心脏病学 心脏病学
- 医疗成像医学成像
- 生物医学科学 生物医学科学
背景情况:
- 心脂肪组织 (EAT) 在心力衰竭中起着复杂的作用.
- 在扩张性心肌病 (DCM) 中EAT的特定作用需要进一步研究.
研究的目的:
- 评估DCM患者中EAT变化与左心室逆转型改造 (LVRR) 之间的关联.
- 在基线和随访时使用心脏磁共振 (CMR) 评估动态EAT变化.
主要方法:
- 预期招募232名DCM患者,基线和随访CMR.
- 患者接受了1-2年的指导方针导向医学治疗 (GDMT).
- 量化了EAT和腹部脂肪;逻辑回归分析了与LVRR的关联.
主要成果:
- 实现LVRR的患者在EAT参数 (心周脂肪厚度,心上脂肪厚度,心下脂肪体积) 中显著增加.
- 增加的EAT与LVRR独立相关 (例如,OR对心表脂肪厚度:2.10).
- 这些关联在调整为BMI和腹部脂肪变化后仍然显著.
结论:
- 在DCM患者的GDMT后,CMR衍生的EAT参数增加.
- 增加的EAT与改善的心室结构和功能有显著的相关性.
- EAT可能在DCM中发挥保护作用,独立于BMI和腹部脂肪.
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...


